scriptaid has been researched along with transforming growth factor beta in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kern, SE; Ryu, B; Sohn, TA; Su, GH | 1 |
Barker, TH; Dudley, AC; Dunleavey, JM; Kim, DJ; Li, W; Ollila, DW; Otey, CA; Troester, MA; Xiao, L | 1 |
2 other study(ies) available for scriptaid and transforming growth factor beta
Article | Year |
---|---|
A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library.
Topics: Cell Survival; Chemistry, Organic; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Genes, Reporter; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Hydroxylamines; Immunoblotting; Luciferases; Organic Chemistry Phenomena; Quinolines; Signal Transduction; Smad4 Protein; Trans-Activators; Transfection; Transforming Growth Factor beta; Tumor Cells, Cultured | 2000 |
Suppression of TGFβ-mediated conversion of endothelial cells and fibroblasts into cancer associated (myo)fibroblasts via HDAC inhibition.
Topics: Animals; Cancer-Associated Fibroblasts; Cell Differentiation; Cell Line, Tumor; Cell Movement; Coculture Techniques; Endothelial Cells; Extracellular Matrix; Fibroblasts; Histone Deacetylase Inhibitors; Humans; Hydroxylamines; Mice; Microarray Analysis; Microscopy, Atomic Force; Neoplasms; Quinolines; Transforming Growth Factor beta; Xenograft Model Antitumor Assays | 2018 |